ArticleSichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition2025
[Relationship Between Neonatal Outcomes and Changes in Serum Platelet-Activating Factor, Fibulin-3, and Umbilical Artery Blood Flow During Late Pregnancy in Pregnant Women With Gestational Hypertension].
Article in Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- [Analysis of Maternal Pregnancy Characteristics and Adverse Neonatal Birth Outcomes at a Single Center From 2017 to 2022].Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To analyze the relationship between changes in platelet-activating factor (PAF), fibulin-3, and umbilical artery blood flow during late pregnancy in pregnant women with gestational hypertension (GH) and neonatal outcomes. Methods: The data of 420 pregnant women with GH who underwent regular prenatal examinations and who delivered at our hospital between January 2020 and December 2024 were collected. The pregnant women were divided into a good outcome group ( Results: Statistically significant differences were observed between the poor outcome group and the good outcome group in terms of age, pre-pregnancy body mass index (BMI), severe GH, PAF, fibulin-3, and umbilical artery blood flow parameters (ratio of peak systolic velocity to end-diastolic maximum velocity [S/D], pulsatility index [PI], and resistance index [RI]) ( Conclusion: Changes in serum PAF, fibulin-3, and umbilical artery blood flow parameters in pregnant women with GH are associated with neonatal outcomes. Increased fibulin-3 is a protective factor, whereas decreased serum PAF level and decreased umbilical artery S/D, PI, and RI are risk factors. The prediction model based on fibulin-3, PAF, S/D, PI, and RI in this study demonstrates high clinical applicability and potential for broader use.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.